Aethlon Medical Q2 2025 Earnings Preview
| AEMD Stock | USD 0.40 0.02 4.76% |
About 61% of Aethlon Medical's investor base is looking to short. The analysis of overall sentiment of trading Aethlon Medical stock suggests that many investors are alarmed at this time. The current market sentiment, together with Aethlon Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Aethlon Medical stock news signals to limit their universe of possible portfolio assets.
Aethlon |
AEMD is set to release Q2 earnings on November 12th with a consensus EPS estimate of -0.20.
Read at seekingalpha.com
 |
Aethlon Medical Fundamental Analysis
We analyze Aethlon Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aethlon Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aethlon Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Aethlon Medical is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Aethlon Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aethlon Medical stock to make a market-neutral strategy. Peer analysis of Aethlon Medical could also be used in its relative valuation, which is a method of valuing Aethlon Medical by comparing valuation metrics with similar companies.
Peers
Aethlon Medical Related Equities
| NPCE | Neuropace | 4.86 | ||||
| CVRX | CVRx | 0.79 | ||||
| BBLG | Bone Biologics | 1.16 | ||||
| SRDX | SurModics | 1.39 | ||||
| SINT | SINTX Technologies | 1.68 | ||||
| NUWE | Nuwellis | 2.63 | ||||
| BJDX | Bluejay Diagnostics | 2.86 | ||||
| HSCS | Heart Test | 4.28 | ||||
| RPID | Rapid Micro | 5.19 | ||||
| VVOS | Vivos Therapeutics | 5.93 | ||||
| DCTH | Delcath Systems | 6.52 | ||||
| TIVC | Tivic Health | 6.54 |
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |